185 related articles for article (PubMed ID: 10625494)
1. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.
Ogretmen B; Safa AR
Biochemistry; 2000 Jan; 39(1):194-204. PubMed ID: 10625494
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
3. RNA helicase A in the MEF1 transcription factor complex up-regulates the MDR1 gene in multidrug-resistant cancer cells.
Zhong X; Safa AR
J Biol Chem; 2004 Apr; 279(17):17134-41. PubMed ID: 14769796
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.
Baran Y; Gunduz U; Ural AU
Exp Oncol; 2006 Jun; 28(2):163-5. PubMed ID: 16837911
[TBL] [Abstract][Full Text] [Related]
5. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity.
Cornwell MM; Smith DE
J Biol Chem; 1993 Sep; 268(26):19505-11. PubMed ID: 8103518
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of three DNA-binding proteins on the promoter of the human MDR1 gene in drug-sensitive and -resistant cells.
Ogura M; Takatori T; Sugimoto Y; Tsuruo T
Jpn J Cancer Res; 1991 Oct; 82(10):1151-9. PubMed ID: 1683350
[TBL] [Abstract][Full Text] [Related]
7. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
[TBL] [Abstract][Full Text] [Related]
8. Demethylation of the human MDR1 5' region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline.
Desiderato L; Davey MW; Piper AA
Somat Cell Mol Genet; 1997 Nov; 23(6):391-400. PubMed ID: 9661702
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells.
Okamura H; Yoshida K; Sasaki E; Morimoto H; Haneji T
Int J Oncol; 2004 Oct; 25(4):1031-7. PubMed ID: 15375553
[TBL] [Abstract][Full Text] [Related]
10. A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity.
Wang X; Talamantez JL; Adamo ML
Endocrinology; 1998 Mar; 139(3):1054-66. PubMed ID: 9492038
[TBL] [Abstract][Full Text] [Related]
11. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene.
Ohga T; Uchiumi T; Makino Y; Koike K; Wada M; Kuwano M; Kohno K
J Biol Chem; 1998 Mar; 273(11):5997-6000. PubMed ID: 9497311
[TBL] [Abstract][Full Text] [Related]
12. Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
Kusaba H; Nakayama M; Harada T; Nomoto M; Kohno K; Kuwano M; Wada M
Eur J Biochem; 1999 Jun; 262(3):924-32. PubMed ID: 10411657
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene.
Ogura M; Takatori T; Tsuruo T
Nucleic Acids Res; 1992 Nov; 20(21):5811-7. PubMed ID: 1360648
[TBL] [Abstract][Full Text] [Related]
14. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress.
Miyazaki M; Kohno K; Uchiumi T; Tanimura H; Matsuo K; Nasu M; Kuwano M
Biochem Biophys Res Commun; 1992 Sep; 187(2):677-84. PubMed ID: 1356336
[TBL] [Abstract][Full Text] [Related]
15. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
Boven E; Jansen WJ; Hulscher TM; Beijnen JH; van Tellingen O
Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
17. Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1).
Vilaboa NE; Galán A; Troyano A; de Blas E; Aller P
J Biol Chem; 2000 Aug; 275(32):24970-6. PubMed ID: 10816597
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia.
Fujimaki S; Funato T; Harigae H; Fujiwara J; Kameoka J; Meguro K; Kaku M; Sasaki T
Clin Chem; 2002 Jun; 48(6 Pt 1):811-7. PubMed ID: 12028995
[TBL] [Abstract][Full Text] [Related]
19. Localization of sequences that influence basal and cell type-specific activity of the murine mdr2 promoter.
Yang CP; Kirschner LS; Yu L; Horwitz SB
Cell Growth Differ; 1996 Sep; 7(9):1227-37. PubMed ID: 8877103
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the human myeloperoxidase promoter region.
Chumakov AM; Chumakova EA; Chih D; Koeffler HP
Int J Oncol; 2000 Feb; 16(2):401-11. PubMed ID: 10639585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
